Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. - Wikidata - awgldk - TriplyDB

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.

http://www.wikidata.org/entity/Q35020913

about

Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics Single and Multiple Gene Manipulations in Mouse Models of Human Cancer Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma Genetic alterations in hepatocellular carcinoma: An update Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes Deletion of Arid1a in Reproductive Tract Mesenchymal Cells Reduces Fertility in Female Mice.Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma.Network-based survival-associated module biomarker and its crosstalk with cell death genes in ovarian cancer.Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma.Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis Global gene expression profiling of a mouse model of ovarian clear cell carcinoma caused by ARID1A and PIK3CA mutations implicates a role for inflammatory cytokine signaling.Potential therapeutic targets in ARID1A-mutated cancers Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.The SWI/SNF BAF-A complex is essential for neural crest development Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer.Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1.Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.(Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes.Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why.Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.Suppression of the SWI/SNF Component Arid1a Promotes Mammalian Regeneration.TGFβ Controls Ovarian Cancer Cell Proliferation Arid1a controls tissue regeneration.The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer.Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.ARID1A-mutated ovarian cancers depend on HDAC6 activity.

P2860

Q26749280-CE9FA488-FEDC-4BB0-8DA3-848F4AAF96D4 Q26775315-16BA68F1-999E-48BC-AD9F-30C63C223643 Q26776098-97F527B1-E095-4F32-9E0C-F3FEA00C256E Q26783920-8261BAF7-AB04-48EF-BEE6-B662F199BC40 Q26784516-BDD21B8F-2CAA-4A66-81B8-FFB8F42FAB86 Q28073241-A35C7C1F-1CA2-4F56-BC9B-E6369567DA56 Q28271584-56CE8847-79DB-4C07-9223-164952E2A108 Q30353348-69D9154B-8A93-40C2-903B-8E0963502B9C Q33734760-A9570BDE-8F0F-4B80-8738-329C0B76D4B1 Q35769650-B54FD14C-2BC7-400C-B4CF-176CAC238D22 Q35841658-24F6C3C9-C32F-404A-9B56-0130BC392452 Q36092550-CB5874E1-49F3-40B2-A1A9-BA9A5CB957DB Q36094489-D9D31779-6B37-48B6-A13B-E9296E2DD77E Q36358757-3678A4CA-BF7A-431C-8BA1-C5D42B9AC291 Q36469778-E3096354-DECF-471F-B563-3936085BCAE1 Q36626976-4E248248-FC87-4FCE-9EC2-9B5AAB28BF3D Q36664117-BE3EEFCE-86CA-4BA0-B1BA-46F22C3148A1 Q36836150-6F90475F-A97A-406F-8153-A7594CE9139D Q36850060-81E8618C-A3B6-41BD-9471-B3C611B1C903 Q37022406-98358E82-30A5-4C58-A0F6-D3DF215FB83E Q37564670-F9104088-31F2-40FE-AF5C-B4E910020235 Q37637147-C7DE32B5-5342-4F3F-9C08-0F36F7BCFF66 Q38787667-151209F8-72A4-422A-A378-EDD15BAF494B Q38889364-FA3F6ADD-223B-4158-921F-1865290568C4 Q38896059-64FBC446-911A-4E80-8506-A85A815D6FF8 Q38913558-199BC06C-20F6-4AFC-9A19-EEED29B3199F Q39365130-618974F6-0097-47D0-9356-8A44CB4DA54C Q39441988-95396E75-8B50-4A4E-BDB5-24E930A86950 Q39998931-3B56570D-3024-4E9D-9BBA-3B47277123A1 Q41573289-B8130920-C0B4-49D3-B7DC-C357AEA2DD9A Q42362913-FD57CDB2-72EE-4A68-AACE-54520DC205CE Q42363612-C4E7410E-58C8-406D-9A16-5D2E465F776B Q42369233-20747672-861C-4CF1-B276-772F6C16F395 Q42378723-8EF43E90-FCAD-40F0-8445-769C9CBE7A20 Q42671513-39CC3237-28DC-455E-96F2-2B8C7F2058F5 Q47133201-0205DB7B-316A-476C-801B-7145ADA862AC Q47240157-6297E6ED-8065-41A3-9DC9-5D2F7552ACD3 Q48124146-F0683286-506D-4625-8D51-31D61D9CC601 Q48227188-8E3C250D-E49E-4370-87EC-E08A7ED1E326 Q48358070-068DE4F1-5504-435B-9BE2-EBD4E59BC183

P2860

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.

http://www.wikidata.org/entity/Q35020913

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Coexistent ARID1A-PIK3CA mutat ...... lammatory cytokine signalling.

@ast

Coexistent ARID1A-PIK3CA mutat ...... lammatory cytokine signalling.

@en

type

label

Coexistent ARID1A-PIK3CA mutat ...... lammatory cytokine signalling.

@ast

Coexistent ARID1A-PIK3CA mutat ...... lammatory cytokine signalling.

@en

prefLabel

Coexistent ARID1A-PIK3CA mutat ...... lammatory cytokine signalling.

@ast

Coexistent ARID1A-PIK3CA mutat ...... lammatory cytokine signalling.

@en

P1433

Q35020913-12D29F72-1486-44F0-8A00-FECF6D963CA0

P1476

Q35020913-9703C561-12BB-4A4B-AE6A-71F3B9FB9D2D

P2093

Q35020913-04787555-35EE-4981-9B78-5EEC557BD8F4

Q35020913-1346CD5B-F815-4B1E-8732-B8C9DAF7F361

Q35020913-2053F8CF-0F78-48AF-B4F5-9E74950B46B5

Q35020913-27FB56B3-05E5-4C9D-824C-EC24FD28C90D

Q35020913-43C4FD44-7574-49AA-9CB1-526E5DCD70E4

Q35020913-80D62ADA-1DC0-4110-BEC4-094027CAFE02

Q35020913-93609FF3-85F6-43C3-90E5-97E8684D25B0

Q35020913-A24E76C8-16AC-4BFF-974F-EBFD2AF6C0CB

Q35020913-A5C056AA-DF67-463F-9E59-4F746F3E9313

Q35020913-C61B6379-0278-46AD-8667-3F67389E1E6A

P2860

Q35020913-00474BD7-583D-48DE-833A-454CFE230720

Q35020913-079AB7CA-D55D-4482-AF30-7E955A41E291

Q35020913-0BAF8B18-6DEA-4DD3-AF89-E5176C912383

Q35020913-0E0823A6-7E9D-4FC4-B54F-BD7849F4E3AA

Q35020913-19908F6E-112F-4AE9-B5A3-862FC11584C2

Q35020913-1D27B5D1-9290-4A6C-A2FF-66BA37352EF0

Q35020913-1F79C215-21D0-4A48-85F4-EC31AB0A0D66

Q35020913-2499DAB9-5C83-4DD7-9431-17F20D481640

Q35020913-262A9BB4-C337-434D-B1D6-6835DCA0A952

Q35020913-294E32B1-522D-45B9-9F88-DB9E810236AB

P2888

Q35020913-697D6393-9290-410D-A389-7F123C281AD8

P304

Q35020913-37F077F0-AEA3-49FA-BA93-A2DA9278DEA3

P31

Q35020913-329C713F-334D-4E5A-8664-D14C0CEECE69

P356

Q35020913-EB05B552-8021-4372-9A5A-A231D35FE0FC

P407

Q35020913-12D5F88C-2435-4F1E-A678-56A758B34D2E

P478

Q35020913-AAEB375F-8A65-40C0-AD07-AFE396EE130A

P50

Q35020913-DE88B43F-1845-4E45-BFE0-D05207DCBF93

Q35020913-E4F1C290-4EAB-4398-AA1C-9360FDAB7281

Q35020913-EA1515FA-E658-4B2B-9BE4-210DB2A05602

P577

Q35020913-9F364C11-5D83-43BC-A4C7-527200A59F5F

P5875

Q35020913-52693CE8-02E5-4293-A555-319100A5CA18

P698

Q35020913-9D3722F7-DF47-48EA-B839-FDF9BC249D46

P921

Q35020913-83899324-DC0B-4C77-A6DD-C406359FCFFE

P932

Q35020913-1EE81AEA-2455-485C-924E-2F1EADD37E41

P356

P1433

Nature Communications

P1476

Coexistent ARID1A-PIK3CA mutat ...... lammatory cytokine signalling.

@en

P2093

Daniel Serber

http://www.w3.org/2001/XMLSchema#string

David B Darr

http://www.w3.org/2001/XMLSchema#string

Della Yee

http://www.w3.org/2001/XMLSchema#string

Fernando Pardo-Manuel de Villena

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Damrauer

http://www.w3.org/2001/XMLSchema#string

Jessie Xiong

http://www.w3.org/2001/XMLSchema#string

Joshua Starmer

http://www.w3.org/2001/XMLSchema#string

Matthew D Wilkerson

http://www.w3.org/2001/XMLSchema#string

Ronald L Chandler

http://www.w3.org/2001/XMLSchema#string

Terry Magnuson

http://www.w3.org/2001/XMLSchema#string

P2860

ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Significance analysis of microarrays applied to the ionizing radiation response

ARID1A mutations in endometriosis-associated ovarian carcinomas

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Cancer statistics, 2013

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Clear cell carcinoma of the female genital tract (not everything is as clear as it seems)

P2888

P304

6118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS7118

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Schisler

P577

2015-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271599406

http://www.w3.org/2001/XMLSchema#string

P698

25625625

http://www.w3.org/2001/XMLSchema#string

P921

P932

4308813

http://www.w3.org/2001/XMLSchema#string